Clinical Trial Update: A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of Azvudine in adults with mild-to-moderate renal impairment and in healthy subjects to inform dosing considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Azvudine (azvudine)

Snippet

Sponsor: Henan Genuine Biotech Co., Ltd. | Conditions: Renal Insufficiency | Phase 1 | Status: RECRUITING